Insights into Acinetobacter baumannii protective immunity
Acinetobacter baumannii is a nosocomic opportunistic Gram-negative bacteria known for its extensive drug-resistant phenotype. A. baumannii hospital-acquired infections are major contributors to increased costs and mortality observed during the COVID-19 pandemic. With few effective antimicrobials ava...
Main Authors: | Sean Jeffreys, James P. Chambers, Jieh-Juen Yu, Chiung-Yu Hung, Thomas Forsthuber, Bernard P. Arulanandam |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-11-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2022.1070424/full |
Similar Items
-
Development and Evaluation of an Immunoinformatics-Based Multi-Peptide Vaccine against <i>Acinetobacter baumannii</i> Infection
by: Sean Jeffreys, et al.
Published: (2024-03-01) -
Editorial: Recent advances in the development of vaccines against Acinetobacter baumannii
by: Saeed Khalili, et al.
Published: (2023-05-01) -
Acinetobacter Baumannii – Virulence Factors and Epidemiology of Infections
by: Marszalik Anna, et al.
Published: (2021-12-01) -
Thioredoxin Modulates Cell Surface Hydrophobicity in Acinetobacter baumannii
by: Holly C. May, et al.
Published: (2019-12-01) -
Pathogenicity factors of Acinetobacter baumannii
by: E. N. Gudueva, et al.
Published: (2023-03-01)